Unraveling the mechanisms of motor neuron degeneration if Spinocerebellar Ataxia, type 1

揭示 1 型脊髓小脑共济失调运动神经元变性的机制

基本信息

  • 批准号:
    9757831
  • 负责人:
  • 金额:
    $ 18.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Spinocerebellar ataxia type 1 (SCA1) is a devastating neurodegenerative disease characterized by progressive ataxia from cerebellar degeneration. Death typically occurs by the third to sixth decade of life. While the hallmark of SCA1 is loss of motor coordination or ataxia, at the end stage of disease premature death results from complications secondary to bulbar dysfunction, including swallowing difficulties and breathing dysfunction. In SCA1, disease is caused by expansion of CAG repeats encoding poly-glutamine (polyQ) in ATAXIN1 (Atxn1). Substantial effort has been invested in determining the molecular mechanism leading to cerebellar degeneration, specifically Purkinje cell death, from polyQ expanded Atxn1. This is largely due to the fact that Purkinje cells seem to be the first neurons affected in SCA1 and they are most vulnerable to the pathogenic sequelae of expanded polyQ Atxn1. However, loss of Purkinje cells does not account for the bulbar dysfunction phenotype, which ultimately causes premature death. I hypothesize that motor neuron degeneration is responsible for bulbar dysfunction in SCA1. Further supporting this hypothesis is SCA1 autopsy data showing marked loss of motor neurons in the brainstem. In 2002 our lab developed a pivotal mouse model for SCA1 recapitulating the major human features of disease with robust face and construct validity. In this model, designated Atxn1-154Q, 154 CAG repeats were knocked into the endogenous mouse Atxn1 gene locus. Upon joining the Zoghbi lab, with my clinical expertise in neuromuscular diseases, I made the exciting observation that these mice display overt signs of motor neuron degeneration. In particular I noted significant muscle wasting, breathing abnormalities and spasticity by 24 weeks of age. The goals of this proposal are to examine motor neurons in Atxn1-154Q mice functionally, morphologically and molecularly in order to better understand what causes their degeneration and to establish these mice as an ideal model to study motor neuron degeneration in SCA1.
项目概要/摘要 脊髓小脑共济失调 1 型 (SCA1) 是一种破坏性神经退行性疾病,其特征是进行性 小脑变性引起的共济失调。死亡通常发生在生命的第三个至第六个十年。虽然 SCA1的标志是运动协调性丧失或共济失调,在疾病末期导致过早死亡 延髓功能障碍继发的并发症,包括吞咽困难和呼吸功能障碍。 在 SCA1 中,疾病是由 ATAXIN1 中编码聚谷氨酰胺 (polyQ) 的 CAG 重复序列扩增引起的 (Atxn1)。人们投入了大量的精力来确定导致小脑的分子机制 PolyQ 扩展的 Atxn1 导致退化,特别是浦肯野细胞死亡。这很大程度上是由于以下事实: 浦肯野细胞似乎是 SCA1 中第一个受影响的神经元,它们最容易受到致病性的影响 扩展的polyQ Atxn1的后遗症。然而,浦肯野细胞的损失并不能解释延髓功能障碍 表型,最终导致过早死亡。我推测运动神经元变性是 导致 SCA1 延髓功能障碍。 SCA1 尸检数据进一步支持了这一假设 脑干运动神经元明显丧失。 2002 年,我们的实验室开发了 SCA1 的关键小鼠模型 具有强大的表面和结构效度来概括疾病的主要人类特征。在这个模型中, 命名为 Atxn1-154Q,154 个 CAG 重复序列被敲入内源性小鼠 Atxn1 基因位点。之上 加入佐格比实验室,凭借我在神经肌肉疾病方面的临床专业知识,我做出了令人兴奋的观察 这些小鼠表现出明显的运动神经元变性迹象。我特别注意到显着的肌肉 24 周龄时出现消瘦、呼吸异常和痉挛。该提案的目标是审查 从功能、形态和分子角度对 Atxn1-154Q 小鼠的运动神经元进行研究,以便更好地理解 是什么导致了它们的退化,并将这些小鼠建立为研究运动神经元的理想模型 SCA1 变性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James P Orengo其他文献

James P Orengo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James P Orengo', 18)}}的其他基金

Investigating Motor Neuron Disease in Spinocerebellar Ataxia, Type1
研究脊髓小脑共济失调 1 型运动神经元疾病
  • 批准号:
    10733124
  • 财政年份:
    2023
  • 资助金额:
    $ 18.94万
  • 项目类别:
Investigating mechanisms of skeletal muscle degeneration in Myotonic Dystrophy
研究强直性肌营养不良骨骼肌变性的机制
  • 批准号:
    7485273
  • 财政年份:
    2008
  • 资助金额:
    $ 18.94万
  • 项目类别:
Investigating mechanisms of skeletal muscle degeneration in Myotonic Dystrophy
研究强直性肌营养不良骨骼肌变性的机制
  • 批准号:
    7574524
  • 财政年份:
    2008
  • 资助金额:
    $ 18.94万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 18.94万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 18.94万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 18.94万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 18.94万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 18.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 18.94万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 18.94万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 18.94万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 18.94万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 18.94万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了